1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone

C23H20N4O2S2 — CID 42089026

IUPAC1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone
SMILESC=CCn1c(SCC(=O)N2N=C(c3cccs3)C[C@H]2c2ccco2)nc2ccccc21
InChIInChI=1S/C23H20N4O2S2/c1-2-11-26-18-8-4-3-7-16(18)24-23(26)31-15-22(28)27-19(20-9-5-12-29-20)14-17(25-27)21-10-6-13-30-21/h2-10,12-13,19H,1,11,14-15H2/t19-/m0/s1
InChIKeyQIRLOZDGVOFQTL-IBGZPJMESA-N
MW448.57 g/mol
LogP5.35
Rot. Bonds7

About 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone

1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone (PubChem CID 42089026) has the molecular formula C23H20N4O2S2 and a molecular weight of 448.57 g/mol. Its IUPAC name is 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone.

Molecular Properties

Compound Name1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone
PubChem CID42089026
Molecular FormulaC23H20N4O2S2
Molecular Weight448.57 g/mol
Exact Mass448.10
IUPAC Name1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone
SMILESC=CCn1c(SCC(=O)N2N=C(c3cccs3)C[C@H]2c2ccco2)nc2ccccc21
InChIInChI=1S/C23H20N4O2S2/c1-2-11-26-18-8-4-3-7-16(18)24-23(26)31-15-22(28)27-19(20-9-5-12-29-20)14-17(25-27)21-10-6-13-30-21/h2-10,12-13,19H,1,11,14-15H2/t19-/m0/s1
InChIKeyQIRLOZDGVOFQTL-IBGZPJMESA-N
XLogP5.35
TPSA63.63 Ų
H-Bond Donors
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500448.57
LogP ≤ 55.35
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone?
The IUPAC name of 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone (CID 42089026) is 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone.
What is the SMILES notation for 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone?
The canonical SMILES for 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone is C=CCn1c(SCC(=O)N2N=C(c3cccs3)C[C@H]2c2ccco2)nc2ccccc21.
What is the InChIKey of 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone?
The InChIKey is QIRLOZDGVOFQTL-IBGZPJMESA-N. The full InChI is InChI=1S/C23H20N4O2S2/c1-2-11-26-18-8-4-3-7-16(18)24-23(26)31-15-22(28)27-19(20-9-5-12-29-20)14-17(25-27)21-10-6-13-30-21/h2-10,12-13,19H,1,11,14-15H2/t19-/m0/s1.
What are the key properties of 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone?
1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone has a molecular weight of 448.57 g/mol, XLogP of 5.35, 7 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[(3S)-3-(furan-2-yl)-5-thiophen-2-yl-3,4-dihydropyrazol-2-yl]-2-(1-prop-2-enylbenzimidazol-2-yl)sulfanylethanone is sourced from PubChem (CID 42089026), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).